IPSEN PHARMA SA
Ipsen Pharma SA develops pharmaceutical products for oncology, endocrinology, and neuromuscular, gastroenterology, cardiovascular, and cognitive disorders.
IPSEN PHARMA SA
Industry:
Pharmaceutical
Founded:
1923-01-01
Status:
Active
Contact:
34 93 685 81 00
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2011-07-26 | Radius Health | Ipsen Pharma SA investment in Series C - Radius Health | 66 M USD |
More informations about "Ipsen Pharma SA"
Ipsen - Wikipedia
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employee…See details»
About Ipsen | Pioneering Biopharmaceutical Company
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society. ... Functioning independently of Ipsen, Fondation Ipsen is dedicated to …See details»
Ipsen – improving patient health outcomes - Ipsen Canada
Ipsen brings 30 years of clinical experience to advancing the understanding of neurological conditions such as spasticity and cervical dystonia. We are a global leader in the research, …See details»
Ipsen - The Org
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. ...See details»
Ipsen Pharma SA - Crunchbase Investor Profile & Investments
Ipsen Pharma SA develops pharmaceutical products for oncology, endocrinology, and neuromuscular, gastroenterology, cardiovascular, and cognitive disorders. Lists Featuring This …See details»
Ipsen - Crunchbase Company Profile & Funding
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Ipsen Pharma SA …See details»
Ipsen Pharma - Overview, News & Similar companies - ZoomInfo
Aug 29, 2024 Popular Searches Ipsen Pharma Ipsen Ipsen Biopharmaceuticals Inc Ipsen Inc Ipsen SA SIC Code 28,283 NAICS Code 32,325 Ticker EPA: IPN Show more. Ipsen Pharma …See details»
IPSEN PHARMA SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IPSEN PHARMA SA of L'HOSPITALET DE LLOBREGAT, Barcelona. Get the latest business insights …See details»
Ipsen Pharma SA - Investments, Portfolio & Company Exits
Jul 26, 2011 Ipsen Pharma SA develops pharmaceutical products for oncology, endocrinology, and neuromuscular, gastroenterology. Search Crunchbase. Start Free Trial . Chrome …See details»
Ipsen SA ESG Risk Rating - Sustainalytics
Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its …See details»
Who We Are - ipsen.com
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society ... Functioning independently of …See details»
Ipsen S.A. (IPN.PA) Stock Price, News, Quote & History - Yahoo …
Find the latest Ipsen S.A. (IPN.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Ipsen SA, IPN:PAR summary - FT.com - Financial Times
6 days ago Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer …See details»
An Overview of Ipsen’s Drug Pipeline | R&D Progress - Patsnap
Sep 10, 2023 Ipsen SA is a pharmaceutical organization that was founded in 1929 and is based in France. The company operates in the field of biomedicine and has a diverse portfolio of …See details»
Ipsen acquiert les droits d'un anticancéreux à la biotech Biomunex
5 days ago Le laboratoire pharmaceutique français Ipsen a annoncé mardi l'acquisition des droits mondiaux d'un anticancéreux de la biotech française Biomunex Phamaceuticals pour un …See details»
Oncologie : Ipsen rachète les droits d’un actif de la biotech …
Le laboratoire français poursuit sa stratégie sur l’oncologie en mettant la main sur un actif, encore en préclinique, ciblant un sous-type de lymphocytes T. Biomunex pourrait toucher jusqu ...See details»
Ipsen: who we are - United States
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society. Media. Back . Media; Press …See details»
Jobs at Ipsen Pharma - December 2024 - Jooble
Jobs at Ipsen Pharma. Explore all 226.000+ current vacancies. Full-time, temporary, and part-time jobs. Competitive salary. Job email alerts. Top employers in United Kingdom and abroad. …See details»
Ipsen rachète les droits mondiaux de l'anticancéreux BMX
5 days ago PARIS (Agefi-Dow Jones)--Le laboratoire pharmaceutique Ipsen a annoncé mardi avoir acquis les droits mondiaux exclusifs de développement et de commercialisation du …See details»
Corporate social responsibility | Ipsen Global
We are proud to announce that Ipsen’s rating has reached an all-time high in the 2024 S&P Global Corporate Sustainability Assessment (CSA). Our score has increased by 4 points, from …See details»